According to this research report, the global Glioblastoma
Multiforme Treatment market has been divided across several regions like North
America, Latin America, Asia-pacific, Europe and Africa. The business profiles
of several leading key players have been described to get a clear understanding
of the competitive landscape. The top-level companies investing in the Glioblastoma
Multiforme Treatment market. This research is an analytical view of various
factors which are driving the progress of the Glioblastoma Multiforme Treatment
market.
For more information about this report visit: https://www.industryglobalnews24.com/global-glioblastoma-multiforme-treatment-market-is-gaining-rising-demand-amongst-
Absolute Markets Insights (AMI) reports a robust forecast for the
global glioblastoma multiforme treatment market during the 2021-2030 period,
growing at a CAGR of 12.67%.
GBM is highly devastating in nature, and can result in the death
of an adult in under six months if the cancer is left undetected or untreated.
Studies show that two out of a hundred thousand individuals are diagnosed with
GBM every year. Based on a report by the Central Brain Tumor Registry of the
United States (CBTRUS), the average age of diagnosis of GBM is around 64 years.
In adults, GBM develops in the cerebrum, a region of the brain that is
responsible for handling many critical neurological processes. The progression
of the disease, especially in adults, can have negative impacts on the quality
of life, and may require palliative care. The need for early diagnosis of the
tumor in adults is highlighted by the fact that the tumor is treatable when it
is relatively small in size, and this can prevent the onset of spillage of the
tumor cells that results in bigger tumor cells in the surrounding region. Reports also show that the males being
affected by GBM is 1.6 times higher as compared to females. Individuals of
Caucasians descent are at a significantly higher risk of developing GBM, as
compared to other races such as African-Americans, Asians, and American
Indians. Also, the chances of the tumor in children is not common. The higher
occurrence of GMB in adults is a major reason for their higher share in the
global glioblastoma multiforme treatment market.
Top Players of Global Glioblastoma Multiforme Treatment
Market are Studied: Some of key players operating in the global
glioblastoma multiforme treatment market are Merck & Co., Inc., Amgen,
Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., DelMar Pharmaceuticals, NOXXON
Pharma, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries
Ltd., Arbor Pharmaceuticals, LLC, Amneal Pharmaceuticals, Karyopharm
Therapeutics, Inc., Sumitomo Dainippon Pharma Oncology, Inc. (Boston
Biomedical, Inc.), amongst others.
Global Glioblastoma Multiforme Treatment Market
By Type of Treatment
·
Surgery
·
Radiotherapy
·
Chemotherapy
·
Tumor treating fields (TTF) therapy
·
Targeted drug therapy
·
Supportive (palliative) care
·
Others
By Mode of Action
·
Immunological
·
Metabolic
·
Pharmacological
By Demographic
·
Kids
·
Adults
By End Users
·
Hospitals and Clinics
·
Research Institutes
·
Pharmaceutical Companies
·
Others
By Region
·
North America
·
Europe
·
Asia Pacific
·
Middle East and Africa
·
Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
The Work Lab,Model Colony, Shivajinagar, Pune, MH, 411016
Website: https://www.absolutemarketsinsights.com/
No comments:
Post a Comment